SBC Medical Group Establishes "SBC AI Longevity Innovation Inc." to Drive AI and Longevity Initiatives
First Product, the "SBC AI Assistant," Introduced at Shonan Beauty Clinic and in Service Since Early August
IRVINE, Calif. -- SBC Medical Group Holdings, Inc. ("SBC"), a Medical Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that it established SBC AI Longevity Innovation Inc. on July 1, 2026. The new subsidiary plans and develops products and services in the AI and longevity fields, with the aim of creating new value in these areas. Its first product is the "SBC AI Assistant," a conversational AI chatbot that responds to customer inquiries on the official website of Shonan Beauty Clinic. In service since early August 2026, the assistant listens to each customer's concerns and preferences through dialogue, guides them to relevant treatment options and information, and then connects them to the reservation routes available through MySBC and the call center.
Helping First-Time Customers Who Are Unsure What to Choose
The official website of Shonan Beauty Clinic carries information on a broad range of treatments, including cosmetic surgery, aesthetic dermatology and laser hair removal, together with pricing, campaigns and clinic details. For customers considering aesthetic healthcare for the first time, however, the sheer volume of information can make it difficult to judge which treatment fits their concerns or what to do next, and some customers have left without reaching the information they needed or completing a reservation.
The SBC AI Assistant uses dialogue to clarify each customer's underlying concerns and preferences, then guides them directly to relevant treatment options and information. By presenting a seamless route to the MySBC membership service and to the call center, it lowers the psychological barrier between an initial question and a booking, and supports a smoother customer experience.
Key Features
Rather than presenting information in one direction, the service uses conversation to work through what customers are interested in and what concerns them. Its main features are as follows.
- Listening to concerns and preferences, and automatically suggesting relevant treatment information
- Immediate answers to pre-visit questions such as pricing, campaigns and clinic access
- Smooth guidance to reservation routes through MySBC and the call center
This creates an environment in which customers can seek advice easily, regardless of time or location, and supports improvement in the customer experience (CX). The assistant provides general information only. It does not make medical diagnoses or determine whether a given treatment is appropriate for an individual. Final diagnosis and the determination of treatment suitability are made by a physician based on an in-person consultation.
SBC regards AI not simply as a tool for operational efficiency, but as a foundation for meaningfully improving both the customer experience and the quality of medical services. SBC will continue to combine clinical knowledge with technology, and to build an environment in which customers can select the medical services best suited to them with confidence.
About SBC AI Longevity Innovation Inc.
SBC AI Longevity Innovation Inc. is an operating company that combines the extensive knowledge and data SBC Medical Group has accumulated in clinical settings with AI technology, with the aim of creating new value in the longevity field and advancing clinic operations and the customer experience on an AI-native basis. Drawing on insights gained from actual clinic operations and customer touchpoints, the company will first focus on planning, developing and implementing products and services within the group. Following the "SBC AI Assistant," it will move toward the practical application of further products that raise the level of day-to-day operations, including the "AI Preceptor" for staff training support, AI-enabled call center support, and data solutions that advance longevity medicine. In the longer term, the company also intends to offer its development and operational expertise to other medical institutions and healthcare-related businesses.
Address: Shinjuku Island Tower 12F, 6-5-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Japan
President and Representative Director: Yuya Yoshida
Established: July 1, 2026
Business: Planning and development of products and services in the AI and longevity fields, and the provision and operational support of AI solutions for medical institutions
Official website: https://sbc-ai-longevity.com/
About SBC Medical Group Holdings, Inc.
SBC Medical Group Holdings, Inc. is a Medical Services Organization that provides management support to medical institutions in Japan and overseas across a wide range of fields, including advanced aesthetic healthcare, dermatology, orthopedics, reproductive medicine, gynecology, dentistry, hair loss treatment (AGA) and ophthalmology. The company operates a portfolio of clinic brands and is expanding into medical tourism as well as the United States and Asia. SBC listed on the NASDAQ market in the United States in September 2024, and was added to the Russell 3000 Index in June 2025. Guided by its group purpose, to contribute to greater happiness for people around the world through medical innovation, SBC will continue to deliver reliable medical services and expand its network.
Company name: SBC Medical Group Holdings Incorporated
Listing: NASDAQ Global Market
Ticker: SBC
Address: 200 Spectrum Center Drive, Suite 300, Irvine, CA 92618, USA
CEO: Yoshiyuki Aikawa
Business: Management support for medical institutions (aesthetic healthcare, dermatology, orthopedics, reproductive medicine, gynecology, dentistry, hair loss treatment (AGA), ophthalmology and others)
Official website: https://sbc-holdings.com
Official LinkedIn page: https://www.linkedin.com/company/sbc-medical-group-holdings-inc
Shonan Beauty Clinic: https://www.s-b-c.net/
Forward-Looking Statements
This press release contains forward-looking statements. These statements are not statements of historical fact or current condition, but reflect only the company's current views regarding future events and performance. Many of these future events and results are inherently uncertain by their nature and are subject to factors beyond the company's control. These forward-looking statements reflect, in particular, the company's current views on its service deployment plans and strategy, revenue and profit growth, and business outlook. Words such as "may," "should," "expect," "anticipate," "intend," "estimate," "believe," "plan," "project," "potential," "target," "hope," and the negative or similar expressions of these terms may be used to identify forward-looking statements. The forward-looking statements in this press release are made as of the date of its distribution and are subject to various risks, uncertainties, assumptions, and changes in circumstances that are difficult to predict or quantify. Readers are therefore cautioned not to place undue reliance on these statements. Forward-looking statements are based on management's current expectations and are not guarantees of future performance. Except as required by law, the company undertakes no obligation to publicly update or revise any forward-looking statement to reflect changes in its expectations or in the events, conditions, or circumstances on which any such statement is based. Actual results may differ materially from current expectations, and new factors may emerge that the company cannot predict in full. Such factors include, among others, changes in global, regional, or national and local economic, business, competitive, market, and regulatory conditions, as well as those described under "Risk Factors" and elsewhere in the company's filings with the U.S. Securities and Exchange Commission (SEC). These filings are available on the SEC website at www.sec.gov.
Contacts
SBC Medical Group Holdings, Inc.
Public Relations Department: Wakiyama
Email: pr@sbc.or.jp